Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/20/2021 73 14
Tipranavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 6 1
Canakinumab Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/19/2021 4 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/19/2021 38 37
Remdesivir Approved by FDA Experimental Antiviral Jan/19/2021 49 4
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/15/2021 28 3
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/15/2021 27 5
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/22/2020 24 5
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Dec/17/2020 10 0
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/14/2020 11 3